Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1527355

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1527355

Global Hyaluronic Acid Market Size Study, by Grade, by Application, by End User, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Hyaluronic Acid Market is valued at approximately USD 6.80 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032. Hyaluronic Acid (HA) is renowned for its extensive skin benefits, including alleviating dry skin, reducing fine lines, wrinkles, redness, and dermatitis. Its remarkable capacity to retain over 1,000 times its weight in water within skin cells makes it an exceptional moisturizer. It boosts skin hydration and collagen production, fights free radicals, and preserves skin elasticity. Additionally, HA functions as a humectant, drawing moisture from the surroundings, which significantly bolsters its utility in skincare products. With the burgeoning demand for anti-ageing and multifunctional personal care products, manufacturers are increasingly incorporating HA into their formulations.

The primary market driver is the growing global consumption of hyaluronic acid, driven by its increasing use in cosmetic, pharmaceutical, and medical applications due to its benefits for skin hydration, joint health, and wound healing. Additionally, rising initiatives by market players, including research and development investments and strategic collaborations, are enhancing product offerings and expanding market reach. On the other hand, market opportunities are emerging from technological advancements in hyaluronic products, which are leading to the development of more effective and safer formulations. Furthermore, the rising prevalence of chronic diseases, such as osteoarthritis, where hyaluronic acid is used for pain management and joint lubrication, is creating additional demand for these products. However, the market faces challenges such as the side effects associated with hyaluronic acid, including potential allergic reactions and inflammation, which raise safety concerns among consumers and healthcare professionals. These concerns can hinder market growth by affecting consumer confidence and regulatory approvals.

The key regions considered for the Global Hyaluronic Acid Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Hyaluronic Acid Market in terms of revenue. The market growth in the region is driven by a sizable geriatric population and a growing demand for minimally invasive cosmetic surgeries. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by high unmet medical needs in emerging economies, increasing awareness of minimally invasive techniques, and rising disposable incomes.

Major market players included in this report are:

  • Allergan
  • Sanofi
  • Genzyme Corporation
  • Anika Therapeutics, Inc.
  • Salix Pharmaceuticals
  • Seikagaku Corporation
  • F. Hoffmann-La Roche Ag
  • Galderma Laboratories L.P.
  • Zimmer Biomet
  • Smith & Nephew Plc
  • Ferring B.V.
  • Lifecore Biomedical, Llc
  • HTL Biotechnology
  • Shiseido Company, Limited
  • Bloomage Biotechnology Corporation Limited

The detailed segments and sub-segment of the market are explained below:

By Grade:

  • Cosmetic Grade
  • Pharmaceutical Grade
  • Food Grade

By Application:

  • Aesthetics
  • Osteoarthritis
  • Pharmaceutical API
  • Cosmetics
  • Dietary Supplements
  • Ophthalmology
  • Others

By End User:

  • Pharmaceutical Industry
  • Dermatology Clinics
  • Cosmetic Surgery Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Hyaluronic Acid Market Executive Summary

  • 1.1. Global Hyaluronic Acid Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Grade
    • 1.3.2. By Application
    • 1.3.3. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Hyaluronic Acid Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Hyaluronic Acid Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Consumption Trends of Hyaluronic Acid Globally
    • 3.1.2. Rising Initiatives by Market Players
  • 3.2. Market Challenges
    • 3.2.1. Side Effects Associated with Hyaluronic Acid
    • 3.2.2. Safety Concerns with Hyaluronic Acid Products
  • 3.3. Market Opportunities
    • 3.3.1. Increasing Technological Advancements in Hyaluronic Products
    • 3.3.2. Rising chronic diseases

Chapter 4. Global Hyaluronic Acid Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Hyaluronic Acid Market Size & Forecasts by Grade 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Hyaluronic Acid Market: Grade Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Cosmetic Grade
    • 5.2.2. Pharmaceutical Grade
    • 5.2.3. Food Grade

Chapter 6. Global Hyaluronic Acid Market Size & Forecasts by Application 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Hyaluronic Acid Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Aesthetics
    • 6.2.2. Osteoarthritis
    • 6.2.3. Pharmaceutical API
    • 6.2.4. Cosmetics
    • 6.2.5. Dietary Supplements
    • 6.2.6. Ophthalmology
    • 6.2.7. Others

Chapter 7. Global Hyaluronic Acid Market Size & Forecasts by End User 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Hyaluronic Acid Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Pharmaceutical Industry
    • 7.2.2. Dermatology Clinics
    • 7.2.3. Cosmetic Surgery Centers
    • 7.2.4. Others

Chapter 8. Global Hyaluronic Acid Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Hyaluronic Acid Market
    • 8.1.1. U.S. Hyaluronic Acid Market
      • 8.1.1.1. Grade breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Hyaluronic Acid Market
  • 8.2. Europe Hyaluronic Acid Market
    • 8.2.1. U.K. Hyaluronic Acid Market
    • 8.2.2. Germany Hyaluronic Acid Market
    • 8.2.3. France Hyaluronic Acid Market
    • 8.2.4. Spain Hyaluronic Acid Market
    • 8.2.5. Italy Hyaluronic Acid Market
    • 8.2.6. Rest of Europe Hyaluronic Acid Market
  • 8.3. Asia-Pacific Hyaluronic Acid Market
    • 8.3.1. China Hyaluronic Acid Market
    • 8.3.2. India Hyaluronic Acid Market
    • 8.3.3. Japan Hyaluronic Acid Market
    • 8.3.4. Australia Hyaluronic Acid Market
    • 8.3.5. South Korea Hyaluronic Acid Market
    • 8.3.6. Rest of Asia Pacific Hyaluronic Acid Market
  • 8.4. Latin America Hyaluronic Acid Market
    • 8.4.1. Brazil Hyaluronic Acid Market
    • 8.4.2. Mexico Hyaluronic Acid Market
    • 8.4.3. Rest of Latin America Hyaluronic Acid Market
  • 8.5. Middle East & Africa Hyaluronic Acid Market
    • 8.5.1. Saudi Arabia Hyaluronic Acid Market
    • 8.5.2. South Africa Hyaluronic Acid Market
    • 8.5.3. Rest of Middle East & Africa Hyaluronic Acid Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Allergan
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Sanofi
    • 9.3.3. Genzyme Corporation
    • 9.3.4. Anika Therapeutics, Inc.
    • 9.3.5. Salix Pharmaceuticals
    • 9.3.6. Seikagaku Corporation
    • 9.3.7. F. Hoffmann-La Roche Ag
    • 9.3.8. Galderma Laboratories L.P.
    • 9.3.9. Zimmer Biomet
    • 9.3.10. Smith & Nephew Plc
    • 9.3.11. Ferring B.V.
    • 9.3.12. Lifecore Biomedical, Llc
    • 9.3.13. HTL Biotechnology
    • 9.3.14. Shiseido Company, Limited
    • 9.3.15. Bloomage Biotechnology Corporation Limited

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!